Jim Sullivan, Ph.D.
InvestorVenture Partner at OrbiMed · Executive at Vanqua Bio · CEO at Vanquabio
Greater Chicago Area
Find your path to Jim
513 people in our graph share verified history with Jim — schools, employers, funds. One of them is your warm intro.
Liz WesthouseunlockedJim: together at Northwestern University (2007–2012)
×3Jim: together at AbbVie
×2Jim: together at Northwestern University
×6Jim: together at Trinity College Dublin
About
Jim Sullivan joined OrbiMed as a Venture Partner in 2019 and serves as CEO of portfolio company Vanqua Bio, which develops therapeutics for neurological conditions such as Parkinson's disease. He previously was Vice President of Research at AbbVie, overseeing research across oncology, immunology, neurology, hepatitis C, and cystic fibrosis, and has advanced more than 100 compounds into clinical development. He holds a bachelor's degree and Ph.D. in biochemistry from Trinity College Dublin, completed postdoctoral research in neurobiology at Northwestern University, and is an adjunct faculty member there.
Invests in
Biotech
Executive at Vanqua Bio
Intro paths
→
In turn, Jim can intro founders to Vanqua Bio's investors below.
CEO at Vanquabio
Intro paths
→
In turn, Jim can intro founders to Vanquabio's investors below.
Experience
- Vanqua BioChief Executive Officercurrent2019 — presentChicago
- OrbiMedVenture Partnercurrent2019 — presentNew York City Metropolitan Area
- Northwestern UniversityAdjunct Professor, Department of Pharmacologycurrent2009 — presentChicago
- AbbVieVice President Global Discovery2013 — 2018Abbott Park, Chicago
- AbbottVice President Global Pharmaceutical Discovery2008 — 2012Abbott Park, IL
- AbbottVice President, Neuroscience Discovery2001 — 2008Abbott Park Chicago
- AbbottDirector Neuroscience Discovery1997 — 2000Abbott Park, Chicago
- AbbottProject Leader1995 — 1997Neuroscience and Urology Research
- AbbottSr Research Scientist, Neuroscience Discovery1991 — 1993Abbott Park
- Nova PharmaceuticalsResearch Scientist1990 — 1991Washington DC-Baltimore Area
- Northwestern UniversityPostdoctoral Fellow, Department of Neurobiology1987 — 1990Evanston, Illinois
Skills & more
Pharmaceutical Industry4Life Sciences3Biotechnology2Clinical Development1Drug Discovery1Clinical TrialsBiopharmaceuticals3Oncology1Immunology1Regulatory Affairs1Neuroscience1Biologics
+2 more
ChemistryMolecular PharmacologyFrom Jim's professional profile.
Investments
Board seats
AliadaVanqua Bio
Per the firm's website.
Colleagues at OrbiMed
Aldo Brambilla
Associate at Silver Lake Partners
Alexander M. Cooper
Investor at OrbiMed
Anat Naschitz
Executive Officer at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Ava Poole
Investor at Insight Partners
Frequently asked questions
- Who is Jim Sullivan, Ph.D.?
- Jim Sullivan joined OrbiMed as a Venture Partner in 2019 and serves as CEO of portfolio company Vanqua Bio, which develops therapeutics for neurological conditions such as Parkinson's disease. He previously was Vice President of Research at AbbVie, overseeing research across oncology, immunology, neurology, hepatitis C, and cystic fibrosis, and has advanced more than 100 compounds into clinical development. He holds a bachelor's degree and Ph.D. in biochemistry from Trinity College Dublin, completed postdoctoral research in neurobiology at Northwestern University, and is an adjunct faculty member there.
- Where does Jim Sullivan, Ph.D. work?
- Jim Sullivan, Ph.D. is Venture Partner at OrbiMed and Executive at Vanqua Bio and CEO at Vanquabio.
- What does Jim Sullivan, Ph.D. invest in?
- Jim Sullivan, Ph.D. invests in Biotech.
- What boards does Jim Sullivan, Ph.D. sit on?
- Jim Sullivan, Ph.D. holds tracked board seats at Aliada, Vanqua Bio.
- Where did Jim Sullivan, Ph.D. go to school?
- Jim Sullivan, Ph.D. studied at Trinity College Dublin (Doctor of Philosophy (Ph.D.), Biochemistry).
Founder mafias
Trinity College Dublin mafia63
Also came through, then founded or led a company.
Eoghan McCabeB.A. (Mod)Founded FinDylan CollinsBAFounded Superawesome +1Patrick FinlayBachelor of Engineering - BEFounded Solidroad +1Colm O'BrienMastersFounded Ulysses +1Karl IagnemmaApplied Mathematics, Fiction WritingFounded nuTonomy +1Anthony QuigleyBScFounded Digital Marketing Institute +1
+ 56 more
AbbVie mafia13
Also came through, then founded or led a company.
Evan MurphySenior Software EngineerFounded Zitara +1Matthew RastovacSoftware Engineering InternFounded Atmos +1Nick GasbarroGovernment Affairs InternFounded CognizantRoss LeimbergDirectorFounded Cantai TherapeuticsDonmienne LeungDirector II, Head of AbbVie Ventures EuropeFounded ThirtyFiveBio LimitedYuga PatelAutomation Engineering InternFounded Ekpa
+ 6 more
OrbiMed mafia10
Also came through, then founded or led a company.
Peter ThompsonGeneral PartnerFounded Cleave Biosciences +4Peter Thompson, M.D.Venture PartnerFounded Cleave Biosciences +4Matthew R. PattersonEntrepreneur-In-ResidenceFounded Audentes Therapeutics +2Iain DukesVenture PartnerFounded Viriom +1Sheila Gujrathi, MDVenture AdvisorFounded Prana Therapies +1Tadd WesselPartnerFounded Petrichor
+ 3 more
Same school
Also attended Trinity College Dublin223
Eoghan McCabeCo-founder & CEO of Fin (formerly Intercom)Justin HallPartner at Golden Gate VenturesBriac BombrunInvestment Associate at Burda Principal InvestmentsBrian SmigaVenture Partner, Co-Founder at Alpha PartnersTom StaffordCo-founder at DST GlobalRichard HurleyManaging Director, Head of IR at Seed Healthcare
+ 217 more
Shared employers
Also worked at Vanqua Bio3
Also worked at Northwestern University128
Liz WesthouseHead of Community & Partnerships, Rise of the Rest at RevolutionAshley PimlottMBA Venture Fellow at Cade VenturesHenry HeitzerDirector at Earth FoundryAgam GuptaPrincipal at SeafundRenana AshkenaziManaging Partner at Grove VenturesTianyi ZhouPrincipal at Linear Capital
+ 122 more
Also worked at AbbVie67
Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures
+ 61 more
Also worked at Abbott195
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundClaire YoonAssociate at Scale Venture PartnersMary PattonScientific Advisory Board at InnoCom Bio EquitiesJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalLaura QuockCBO-in-Residence at Versant VenturesCharles BeyrouthyFounder & Managing Partner at Forma Prime
+ 189 more